​The event is full!! We will admit additional people from the waitlist if new tickets open up. See you all on Sunday!

​[LIMITED CAPACITY: CONFIRMED GUESTS ONLY❗️]

​🗒️ Summary:

​Welcome to the Longevity Investor Network's pre-JPM event, where top innovators in longevity science and biotech venture capital come together to transform the future of healthcare.

​This exclusive gathering brings together leading experts, visionaries, and enthusiasts from around the world to explore groundbreaking advancements in extending human lifespan and empowering individual health choices.

​Join us for an inspiring evening as we dive into the latest in longevity medicine, biotechnology, and the investment landscape driving these fields forward. Discover how you can contribute to accelerating research and shaping the future of longevity.

​Special Guest Speakers: Bruno Balen (Linkedin, AniBiome), Frank Ahmann (Linkedin, XM Therapeutics), Reason (Linkedin, RepairBiotechnologies, Fight Aging!), Hans Keirstead (Linkedin, Immunis), Bobby Brooke (Linkedin, InterveneImmune), Dr. José Navarro-Betancourt (Linkedin, Quadrascope)

🧠 TOPICS:

​​​This networking event will host a series of short focus talks on important longevity topics in the following areas:

• ​Bruno Balen:

  • ​Presenting an AI algorithm that deciphers affectoneuroimmunology (ANI)—the science exploring how emotions and molecular pathways interact to influence aging biology in a dynamic, bidirectional process.

• ​Frank Ahmann:

  • ​Presenting on the how to modulate the dysfunctional Extra Cellular Matrix (ECM) by injectable, acellular designer ECM particles sourced from human 3D cell cultures

• ​Reason:

  • ​How to develop the capability to rapidly reverse atherosclerosis and plaque build up, rather than merely slowing down its progression. (Up until now the largest cause of human mortality remains cardiovascular disease. No therapy, or even intensive combination of therapies, have shown to reliably and rapidly reduce plaque size and overall plaque burden)

• ​Hans Keirstead

  • ​How to develop novel methods to grow human stem cells for clinical use, and direct them to become highly pure populations of defined cells that secrete factors which benefit immune system development, modulation, and health. With age, every person experiences a reduction of factors which benefit immune system development, modulation, and health.

• ​Bobby Brooke

  • ​How to measure thymus regeneration. Sharing results of the ongoing TRIIM-X trial that evaluates a personalized combination treatment regimen for thymus regeneration. The study is generating data leveraging biomarkers for aging and immunosenescence, it also evaluates clinical measures and risk factors for prevention of physical frailty, cancer, cardiovascular disease, diabetes, dementia, and also infectious diseases, including flu and COVID-19. The study uses multiple agents in combination with personalized doses of recombinant human growth hormone (somatropin), metformin, and DHEA.

• ​Dr. José Navarro-Betancourt

  • ​Scientific Director of quadraScope Ventures, will share real-life stories about how the companies in the fund’s portfolio are solving biological aging.  quadraScope invests in early-stage healthcare companies that enable disease treatment and prevention through biological age reversal.

​

​📝 DETAILS:

​​​• Why join? This event offers a unique opportunity to dive into new topics, connect with like-minded individuals, and open doors to exciting possibilities—even the chance to build and/or invest in your next company! You might meet a future portfolio company, collaborator, mentor, or investor, or spark an idea that could lead to the next major startup or scientific breakthrough!

​​​• Who Should Join? The select audience will be comprised of Investors, Family Offices, Corporate Biotech Venture Partners with select researchers and startups operating in the longevity biotech field.

​🗓️ SCHEDULE:

​Sunday January 12th, 2025

​​• 2:40PM: Check-In & Networking

​​• 3:20PM-3:40PM: Bruno Balen - Presenting on the largest-ever longitudinal longevity trial that will collect the biggest multi-omic data set and open-source it to academia!

​​• 3:40PM-4:00PM: Frank Ahmann - Presenting on the how to modulate the dysfunctional Extra Cellular Matrix (ECM) by injectable, acellular designer ECM particles sourced from human 3D cell cultures.

​​• 4:00PM-4:20PM:​ Hans Keirstead - from Immunis, presenting on Immunis and their mission to maximize health and to minimize disease through the development of novel, stem cell-derived therapies. Their innovative, multi-active biologics harness the benefits of hundreds of secreted stem cell factors. Together, these components have the power to influence multiple cellular pathways and the flexibility to address several elements of age-related disease.

​• 4:20PM-4:50PM: - Networking

​​• 4:50PM-5:10PM: Reason! - How to develop the capability to rapidly reverse atherosclerosis and plaque build up, rather than merely slowing down its progression.

​​• 5:10PM-5:30PM: Bobby Brooke - Presenting on how to measure thymus regeneration. Sharing results of the ongoing TRIIM-X trial that evaluates a personalized combination treatment regimen for thymus regeneration. The study uses multiple agents in combination with personalized doses of recombinant human growth hormone (somatropin), metformin, and DHEA.

​​• 5:30PM-5:50PM: Dr. José Navarro-Betancourt - Presenting real-life stories about how companies in the Quadrascope fund portfolio are solving biological aging and what is the future of longevity VentureCapital.

​​• 5:50PM-6:20PM: Networking

​🤝 INVESTOR ATTENDEES:

​Investors From: Longevity Investor Network, Longevity Vision Fund, BoxOne Ventures, SOS Ventures, Maximon, Juvenescence, 5AM Ventures, CambrianBio, AltosLabs, Canaan Partners, LongeVC, Methuselah Foundation, CurieBio, Centenarian Fund, Formic Ventures, Khosla Ventures, Prime Movers Lab, Life Science Angels, Emerging Longevity Ventures, HOF Capital, Kaiser Pernamente Ventures, OrbiMed, IndieBio, Apollo Health Ventures, Age1, LongevityTechFund and more

​⭐️ ATTENDANCE:

• ​Hungry? Snacks and beverages are provided!

• ​Where: Shack 15 (Hulen Room)

• ​[LIMITED CAPACITY - CONFIRMED GUESTS ONLY❗️]

​ℹ️ The Longevity Investor Network:

​The Longevity Investor Network is an industry-leading platform that connects investors with promising rejuvenation biotech startups. Organized and run by Lifespan Research Institute, the network brings together over 350 investors in formal monthly meetings to learn, network, and hear pitches from cutting-edge entrepreneurs working in therapeutics, diagnostics, clinics, AI drug discovery, data platforms, supplements, and more.

​Lifespan Research Institute is a 501(c)(3) nonprofit formed as a result of the recent merger between Lifespan.io and SENS Research Foundation.